WeVote
Log In

Bill

Bill

SB 1256

Drugs, Prescription - As introduced, requires the department of finance and administration, in collaboration with the department of health and the bureau of TennCare, to apply for federal approval to import prescription drugs from Canada. - Amends TCA Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71.

114th Regular Session (2025-2026) Introduced by London Lamar

Tennessee directs state agencies to seek federal approval to import prescription drugs from Canada, potentially lowering costs but facing regulatory and legal obstacles.

Assigned to General Subcommittee of Senate Commerce and Labor Committee
#drugs #prescription
0
WeVote Research Nonpartisan
Bill Summary · SB 1256

Legislative bill overview

SB 1256 directs Tennessee's Department of Finance and Administration to partner with the Department of Health and TennCare to seek federal approval for importing prescription drugs from Canada. The bill amends multiple state codes to facilitate this importation process and establish necessary regulatory frameworks.

Why is this important

Prescription drug costs in the United States are significantly higher than in Canada, potentially reducing healthcare expenses for Tennessee residents and the state's Medicaid program. However, this approach requires federal authorization and raises questions about drug safety oversight, supply chain integrity, and whether it can legally operate within current federal law.

Potential points of contention

  • Federal legality concerns: The FDA has historically restricted direct drug imports from Canada, citing safety and supply-chain verification challenges. Obtaining federal approval may be legally or practically difficult.
  • Pharmaceutical industry opposition: Drug manufacturers may challenge this through legal or lobbying efforts, as it could pressure prices nationally and reduce their profit margins.
  • Drug safety and quality control: Questions exist about verifying Canadian drug authenticity, ensuring proper storage/handling during transport, and maintaining cold-chain integrity for temperature-sensitive medications.
  • State-federal regulatory conflict: Unclear whether Tennessee can unilaterally authorize importation or if federal action must occur first, creating implementation uncertainty.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.